Clinical Study

Ocarina

Posted Date: Oct 7, 2019

  • Investigator: Lawrence Goldstick
  • Specialties: Multiple Sclerosis, Neurology
  • Type of Study: Drug

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis

Criteria:

Patients With Multiple Sclerosis Previously Treated With Ocrelizumab For At Least One Year, Or Patients Who Have Never Received Ocrelizumab

Keywords:

Primary Progressive Ms, Relapsing Remitting Ms

For More Information:

Melissa Gilchrist
9375355014
melissa.gilchrist@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.